{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:47:29Z","timestamp":1791586049226,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515011350"],"award-info":[{"award-number":["2024A1515011350"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023B03J0029"],"award-info":[{"award-number":["2023B03J0029"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023B1111020005"],"award-info":[{"award-number":["2023B1111020005"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","award":["2023B1515130009"],"award-info":[{"award-number":["2023B1515130009"]}],"id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073882"],"award-info":[{"award-number":["82073882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20421"],"award-info":[{"award-number":["U21A20421"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573222"],"award-info":[{"award-number":["82573222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018573","name":"Sun Yat-sen University Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFE0209700"],"award-info":[{"award-number":["2022YFE0209700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011276","name":"State Key Laboratory of Oncology in South China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drup.2026.101442","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:07:08Z","timestamp":1783091228000},"page":"101442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy"],"prefix":"10.1016","volume":"88","author":[{"given":"Xueping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.W.","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-2506","authenticated-orcid":false,"given":"Liwu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101442_bib1","doi-asserted-by":"crossref","first-page":"eadq6830","DOI":"10.1126\/sciadv.adq6830","article-title":"Ex vivo modeling of precision immuno-oncology responses in lung cancer","volume":"10","author":"Alsaed","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2026.101442_bib2","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1038\/s41467-025-61442-5","article-title":"Cellular crosstalk mediated by TGF-\u03b2 drives epithelial-mesenchymal transition in patient-derived multi-compartment biliary organoids","volume":"16","author":"Ayabe","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101442_bib3","doi-asserted-by":"crossref","first-page":"15548","DOI":"10.1073\/pnas.2536483100","article-title":"TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest","volume":"100","author":"Bhowmick","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101442_bib4","article-title":"Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci. (Weinheim Baden-Wurttemberg Germany)"},{"key":"10.1016\/j.drup.2026.101442_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.it.2018.07.001","article-title":"Humanized Mice for the Study of Immuno-Oncology","volume":"39","author":"De La Rochere","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.drup.2026.101442_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s44276-025-00174-x","article-title":"Evaluating the significance of combining PD-L1 and TILs as biomarkers in non-small cell lung cancer patients treated with immunotherapy: a systematic review","volume":"3","author":"Derraze","year":"2025","journal-title":"BJC Rep."},{"key":"10.1016\/j.drup.2026.101442_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101442_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aao6897","article-title":"VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP beta2-chimaerin","volume":"11","author":"Elaimy","year":"2018","journal-title":"Sci. Signal"},{"key":"10.1016\/j.drup.2026.101442_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-019-0832-4","article-title":"Emerging organoid models: leaping forward in cancer research","volume":"12","author":"Fan","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib11","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.4103\/1673-5374.391193","article-title":"p38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced retinal excitotoxicity glaucoma model","volume":"19","author":"Feng","year":"2024","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.drup.2026.101442_bib12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.2024.5814","article-title":"Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis","volume":"331","author":"Feng","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.drup.2026.101442_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","article-title":"Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance","volume":"15","author":"Fu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/mt.2015.10","article-title":"The clinical relevance of the miR-197\/CKS1B\/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer","volume":"23","author":"Fujita","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drup.2026.101442_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.drup.2026.101442_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00262-025-04225-7","article-title":"Construction and application of a humanized mouse model for prostate cancer in immunotherapy","volume":"74","author":"Guo","year":"2025","journal-title":"Cancer immunol. immunother. CII"},{"key":"10.1016\/j.drup.2026.101442_bib17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jtho.2020.04.026","article-title":"Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC","volume":"15","author":"Hong","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2026.101442_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1470-2045(21)00405-8","article-title":"Pathological complete response as a surrogate endpoint after neoadjuvant therapy for lung cancer","volume":"22","author":"Huynh","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1299303","article-title":"Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma","volume":"6","author":"Jacquelot","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.drup.2026.101442_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302331","article-title":"Patient-Derived Organoids as Therapy Screening Platforms in Cancer Patients","volume":"13","author":"Khorsandi","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.drup.2026.101442_bib22","doi-asserted-by":"crossref","first-page":"10861","DOI":"10.1158\/0008-5472.CAN-06-2565","article-title":"Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress","volume":"66","author":"Kirshner","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101442_bib23","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1158\/1078-0432.CCR-16-1293","article-title":"FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib","volume":"22","author":"Larkins","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101442_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12935-024-03628-3","article-title":"Novel research model for in vitro immunotherapy: co-culturing tumor organoids with peripheral blood mononuclear cells","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.drup.2026.101442_bib25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.stem.2025.05.011","article-title":"An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer","volume":"32","author":"Li","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drup.2026.101442_bib26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/19420862.2018.1518948","article-title":"Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1\/PD-1 targeted immunotherapy","volume":"10","author":"Lin","year":"2018","journal-title":"MABS-Austin"},{"key":"10.1016\/j.drup.2026.101442_bib27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1091\/mbc.e11-10-0849","article-title":"Attenuation of TGF-beta signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells","volume":"23","author":"Lin","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.drup.2026.101442_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nprot.2016.174","article-title":"Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens","volume":"12","author":"Liu","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.drup.2026.101442_bib29","first-page":"998","article-title":"Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non-Small Cell Lung Cancer, Clinical cancer research: an official journal of the American Association for","volume":"30","author":"Lopez De Rodas","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101442_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008146","article-title":"HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype","volume":"12","author":"Luo","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2026.101442_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s40425-019-0733-7","article-title":"Niclosamide, an antihelmintic drug, enhances efficacy of PD-1\/PD-L1 immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Luo","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2026.101442_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41392-023-01545-x","article-title":"A20 promotes colorectal cancer immune evasion by upregulating STC1 expression to block \"eat-me\" signal","volume":"8","author":"Luo","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2026.101442_bib33","article-title":"SAA1 Induces TGF-\u03b21 Secretion by Ovarian Cancer Cells, Leading to M2 Macrophage Polarization and Inhibition of NK Cell Activity","volume":"39","author":"Ma","year":"2025","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.drup.2026.101442_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tcb.2024.10.004","article-title":"The culture and application of circulating tumor cell-derived organoids","volume":"35","author":"Pan","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drup.2026.101442_bib35","article-title":"Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research","volume":"6","author":"Park","year":"2024","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.drup.2026.101442_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jamaoncol.2016.0333","article-title":"Treatment of EGFR-Mutant Lung Cancers After Progression in Patients Receiving First-Line EGFR Tyrosine Kinase Inhibitors: A Review","volume":"2","author":"Piotrowska","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101442_bib38","article-title":"Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.drup.2026.101442_bib39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/cells14100741","article-title":"Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy","volume":"14","author":"Saeed","year":"2025","journal-title":"Cells-BASEL"},{"key":"10.1016\/j.drup.2026.101442_bib40","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/annonc\/mdw041","article-title":"Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies","volume":"27","author":"Sanmamed","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41416-019-0616-1","article-title":"Patient-derived organoids as a potential model to predict response to PD-1\/PD-L1 checkpoint inhibitors","volume":"121","author":"Scognamiglio","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2026.101442_bib42","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s41467-022-29857-6","article-title":"Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101442_bib43","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2026.101442_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccell.2015.12.002","article-title":"A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas","volume":"29","author":"Soragni","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2026.101442_bib45","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science (New York N. Y. )"},{"key":"10.1016\/j.drup.2026.101442_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218145","article-title":"Current advances and future directions of combined ICIs and TILs in solid tumors","volume":"636","author":"Wang","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101442_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12943-020-01200-x","article-title":"The biomarkers of hyperprogressive disease in PD-1\/PD-L1 blockage therapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101442_bib48","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.drup.2026.101442_bib49","doi-asserted-by":"crossref","unstructured":"R. Wickramasekara, V. Jones, Y. Zhao, S. Luo, G. Sun and R. Huang, Mechanisms of therapy resistance in the tumor microenvironment: Insights from antibody array-based cytokine profiling, Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 86 (2026), p. 101378.","DOI":"10.1016\/j.drup.2026.101378"},{"key":"10.1016\/j.drup.2026.101442_bib50","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamaoncol.2016.0016","article-title":"Association of BIM Deletion Polymorphism With Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Patients With Lung Adenocarcinoma","volume":"2","author":"Wu","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.drup.2026.101442_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2026.101442_bib52","first-page":"145","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2026.101442_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/215798","article-title":"Protective effects of p38 MAPK inhibitor SB202190 against hippocampal apoptosis and spatial learning and memory deficits in a rat model of vascular dementia","volume":"2013","author":"Yang","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.drup.2026.101442_bib54","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2337\/db11-1306","article-title":"Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice","volume":"61","author":"Yi","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.drup.2026.101442_bib55","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.celrep.2018.09.072","article-title":"Long-Term In Vitro Expansion of Epithelial Stem Cells Enabled by Pharmacological Inhibition of PAK1-ROCK-Myosin II and TGF-beta Signaling","volume":"25","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101442_bib56","article-title":"Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101442_bib57","article-title":"Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2026.101442_bib58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:49:57Z","timestamp":1784836197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"alternative-id":["S1368764626000932"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101442","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101442"}}